Filter posts

BIO and Universities Caution Against Innovation Act, Emphasize the Need for Patent Protection

In light of House Judiciary Committee Chairman Bob Goodlatte’s (R-VA) re-introduction of the Innovation Act, …

Forbes Asks: Should Economists Perform Surgery and Doctors Conduct Economic Policy?

Over at Forbes, University of Chicago economist Tomas Philipson has an insightful post analyzing several …

Unleashing the Full Promise of Biotechnology Innovation

Last week, I attended the announcement of President Obama’s Precision Medicine Initiative at the White …

Does a "non-G.M.O" Label Really Mean without GMOs?

In her article, Many G.M.O.-Free Labels, Little Clarity Over Rules, Stephanie Strom examines the issues behind …

Measles Outbreak Shows Dangers of Vaccine Misinformation

On Sunday, Centers for Disease Control (CDC) Director Tom Friedan said that the U.S. could …

BIO Deputy General Counsel Remarks on Revised Eligibility Guidance

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent …